BBR induces apoptosis in human liver cancer cells by upregulating P53 (107), downregulating CD147 (108), increasing Bax expression, activating caspases 3 and 9 (109), promoting AMPK phosphorylation, and inhibiting Akt phosphorylation (110). This evidence concerns the gene TP53 and liver cancer.